---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-012393"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2026-04-15T23:59:59+00:00"
generated_at: "2026-05-15T06:08:11.111483+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision shareholders approve reverse split (1:2-1:100) and preferred share issuances

## Summary
- All six proposals passed at April 15 special meeting; 49.5% of outstanding shares voted.
- Reverse stock split authorized at ratio between 1-for-2 and 1-for-100, at board's discretion.
- Issuance of common stock underlying Series C-1, C-2, C-3, C-4 convertible preferred approved (690,693 for).
- Issuance of shares underlying Series D and Series J convertible preferred also approved (~690,600 votes for each).
- Approval of conversion price reduction for Series B convertible preferred stock (690,825 for).

## SEC filing metadata
- accession: 0001437749-26-012393
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2026-04-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000143774926012393/0001437749-26-012393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000143774926012393/vtak20260410_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-012393
- JSON: https://secwatch.observer/filing/0001437749-26-012393.json
- Plain text: https://secwatch.observer/filing/0001437749-26-012393.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.